Variability in drug efficacy and drug safety is a leading challenge in current clinical practice
59% of American adults take at least one medication, and 15% take 5 or more
1.1 million emergency department visits and 272,000 hospitalizations are due to adverse drug events annually
$3.5 billion is spent on extra medical costs for adverse drug events annually
Pre-emptive pharmacogenomic testing prevents 20% of adverse drug events
Help predict a patient’s medical and pharmaceutical response
Pharmacogenomics is an important tool in helping to understand how patients metabolize medications based on their DNA, and it is a pillar in the personalized medicine movement. 2 out of 3 individuals take medications that are impacted by pharmacogenomics.